deferasirox has been researched along with Cardiomyopathy, Congestive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamdan, MA; Hayek, M; Ishaqi, MK; Jamil, A; Khanani, MF; Shamsi, A; Trad, O | 1 |
| Fernandes, JL | 1 |
1 review(s) available for deferasirox and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Iron chelation therapy in the management of transfusion-related cardiac iron overload.
Topics: Benzoates; Cardiomyopathy, Dilated; Chelation Therapy; Cross-Sectional Studies; Deferasirox; Deferiprone; Deferoxamine; Double-Blind Method; Drug Therapy, Combination; Forecasting; Humans; Iron Chelating Agents; Iron Overload; Magnetic Resonance Imaging; Practice Guidelines as Topic; Prospective Studies; Pyridones; Randomized Controlled Trials as Topic; Retrospective Studies; Transfusion Reaction; Treatment Outcome; Triazoles; Ventricular Dysfunction, Left | 2012 |
1 other study(ies) available for deferasirox and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Reversal of iron-induced dilated cardiomyopathy during therapy with deferasirox in beta-thalassemia.
Topics: Adolescent; Benzoates; beta-Thalassemia; Cardiomyopathy, Dilated; Deferasirox; Humans; Iron; Male; Triazoles | 2009 |